Alunbrig

E1188113 UNEXPLORED

Alunbrig is a targeted cancer therapy drug (brigatinib) used primarily to treat certain types of ALK-positive non-small cell lung cancer.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Alunbrig canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Ariad Pharmaceuticals → brigatinibBrandName → Alunbrig ⓘ